2015-11-16T17:44:13-06:00 2014-12-31 410746749 CLIFTONLARSONALLEN LLP 4250 N FAIRFAX DRIVE SUITE 1020 ARLINGTON VA 22203 990 2014-01-01 521224577 BIOTECHNOLOGY INDUSTRY ORGANIZATION BIOT 2029629200 1201 MARYLAND AVENUE SW NO 900 WASHINGTON DC 20024 JOANNE M DUNCAN CFO & SVP, FINANCE & ADMIN 2029629200 2015-11-13 1 DAVID TRIMNER P00444822 5712279500 2014 2016-04-25 22:37:26Z JAMES C GREENWOOD 1201 MARYLAND AVENUE SW NO 900 WASHINGTON DC 20024 96967799 0 X WWW.BIO.ORG X 1993 DC THE BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) MISSION IS TO SUPPORT THE BIOTECHNOLOGY INDUSTRY TO EXPAND THE BOUNDARIES OF SCIENCE TO BENEFIT MANKIND BY PROVIDING BETTER HEALTH CARE, ENHANCED AGRICULTURE AND A CLEANER AND SAFER ENVIRONMENT. IT IS BIO'S MISSION TO BE THE CHAMPION OF BIOTECHNOLOGY AND THE ADVOCATE OF OUR MEMBER ORGANIZATIONS - BOTH LARGE AND SMALL. 107 107 190 225 374180 0 0 0 60759645 58986031 4800278 3035059 20773 4796209 65580696 66817299 664500 588500 0 0 29774878 30326647 0 0 0 35737171 35217817 66176549 66132964 -595853 684335 66638973 68085013 26153882 26015982 40485091 42069031 X THE BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) REPRESENTS APPROXIMATELY 1,000 COMPANIES AND ORGANIZATIONS IN WASHINGTON DC, STATE CAPITALS, AND INTERNATIONAL FORA. BIO IS FOUNDED ON THE PRINCIPLE THAT POLICY MUST NURTURE INNOVATION IN THE LIFE SCIENCES TO OVERCOME CHALLENGES IN HEALTH CARE, AGRICULTURE, INDUSTRY, AND THE ENVIRONMENT. OUR MEMBERS REPRESENT COMPANIES OFFERING A SPECTRUM OF BIOTECHNOLOGY APPLICATIONS ACROSS MAJOR SECTORS OF THE ECONOMY. BIO MEMBERS ALSO INCLUDE UNIVERSITIES, NONPROFITS, PATIENT GROUPS, AND OTHER ORGANIZATIONS THAT PLAY AN IMPORTANT ROLE IN THE FUTURE OF THE LIFE SCIENCES. BIO'S ACTIVITIES ARE BROKEN DOWN INTO TWO PROGRAMS - ADVOCACY AND SERVICES. 0 0 ADVOCACYBIO'S ADVOCACY EFFORTS REFLECT THE PRIORITIES IDENTIFIED BY THE BIO BOARD OF DIRECTORS AND THE FOUR SECTION GOVERNING BOARDS.THE BOARD OF DIRECTORS FOCUSES ON ISSUES OF IMPORTANCE TO ALL BIO MEMBERS, REGARDLESS OF THEIR SIZE OR TECHNOLOGY. THESE CROSS-CUTTING ADVOCACY ACCOMPLISHMENTS IN 2014 ARE LISTED BELOW: - SAFEGUARDED AND ADVANCED INTELLECTUAL PROPERTY PROTECTIONS, DOMESTICALLY AND INTERNATIONALLY.- FOSTERED A DIALOGUE ABOUT ETHICS AND PROACTIVELY ADVANCED THE SOCIALLY RESPONSIBLE USE OF BIOTECHNOLOGY.- PROMOTED INVESTMENT IN GOVERNMENT AND ACADEMIC RESEARCH.- PROMOTED COMPREHENSIVE REFORM OF THE U.S. TAX CODE TO SPUR INNOVATION AND INVESTMENT IN BIOTECHNOLOGY.- EXPANDED OUTREACH TO FOREIGN GOVERNMENTS AND INTERNATIONAL ENTITIES TO EDUCATE ON POLICY ISSUES OF IMPORTANCE TO THE BIOTECHNOLOGY INDUSTRY AND TO IMPROVE THE INVESTMENT AND REGULATORY CLIMATE FOR BIOTECH PRODUCTS.THE HEALTH SECTION 2014 ADVOCACY ACCOMPLISHMENTS:- INFLUENCED IMPROVEMENTS TO THE U.S. FOOD AND DRUG ADMINISTRATION'S (FDA'S) PROCESS FOR HUMAN DRUG REVIEW.- ENHANCED AND PROTECTED PATIENT ACCESS TO INNOVATIVE THERAPIES.- ADVOCATED FOR BIOSIMILAR POLICIES THAT PROTECT PATIENT SAFETY AND PROMOTE BIOMEDICAL INNOVATION.- PROMOTED DEVELOPMENT AND USE OF RESEARCH TOOLS, MOLECULAR DIAGNOSTICS AND PERSONALIZED THERAPIES. - ADVOCATED FOR POLICIES THAT FOSTER VACCINE INNOVATION AND PROMOTE PANDEMIC AND BIO-DEFENSE PREPAREDNESS.- INFLUENCED IMPROVEMENTS TO THE INTERNATIONAL ENVIRONMENT FOR BIOMEDICAL INNOVATION.THE EMERGING COMPANIES SECTION 2014 ADVOCACY ACCOMPLISHMENTS: - ADVANCED THE INTEREST OF EMERGING COMPANIES IN HEALTH, REGULATORY, CAPITAL FORMATION, TAX, AND FINANCIAL SERVICES POLICY.- ADVOCATED FOR TAX POLICIES SUPPORTING INNOVATIVE EMERGING COMPANIES AND INVESTMENT IN GROUNDBREAKING R&D.- ADVOCATED FOR THE REMOVAL OF BURDENSOME FINANCIAL REPORTING REGULATIONS ON EMERGING COMPANIES, AND FOR ENHANCED FINANCIAL PATHWAYS TO CAPITAL FORMATION.- INFLUENCED BIO'S HEALTH CARE POLICIES TO REFLECT THE CONCERNS OF SMALL BIOTECHNOLOGY COMPANIES.THE FOOD & AGRICULTURE SECTION 2014 ADVOCACY ACCOMPLISHMENTS: - WORKED WITH THE ADMINISTRATION AND CONGRESS TO ADVANCE IMPROVEMENTS TO THE U.S. AND GLOBAL REGULATORY SYSTEMS IN AN EFFORT TO PROVIDE PREDICTABILITY IN REGULATORY DECISIONS. - WORKED WITH MEMBERS OF THE AGRICULTURAL VALUE CHAIN, LARGELY THROUGH THE U.S. BIOTECH CROPS ALLIANCE (USBCA), TO ADDRESS TRADE ISSUES IN AGRICULTURAL EXPORT MARKETS SUCH AS CHINA AND EUROPE. - FOSTERED A DIALOGUE WITH CONSUMERS AIMED AT ADDRESSING CONCERNS ABOUT GMOS. - PARTICIPATED IN THE LAUNCH OF THE COALITION FOR SAFE AFFORDABLE FOOD, AN ALLIANCE OF OVER 30 MEMBERS FROM ACROSS THE SUPPLY CHAIN, TO ADVANCE FEDERAL GMO FOOD LABELING UNIFORMITY. - WORKED WITH AGRICULTURAL INDUSTRY ALLIES TO OPPOSE FEDERAL AND STATE-LEVEL INITIATIVES AIMED AT MANDATING GMO FOOD LABELING.- MOUNTED LEGAL CHALLENGES TO PRESERVE THE RIGHTS OF FARMERS TO PLANT GENETICALLY ENGINEERED CROPS.THE INDUSTRIAL & ENVIRONMENTAL SECTION 2014 ADVOCACY ACCOMPLISHMENTS: - SUCCESSFULLY ADVOCATED FOR CONGRESS TO PRESERVE THE RENEWABLE FUELS STANDARD.- WORKED TO ENSURE THE APPROPRIATE IMPLEMENTATION OF THE FEDERAL FARM BILL LEGISLATION AND TO ENSURE KEY PROVISIONS WERE EXTENDED TO RENEWABLE CHEMICALS. - SUCCESSFULLY ADVOCATED FOR FUNDING OF THE NAVY GREEN FLEET INITIATIVE AND DEFENSE BIOFUELS MOU. SERVICESBIO'S SERVICES INCLUDE CONFERENCES AND ACTIVITIES THAT BRING TOGETHER INDUSTRY PARTNERS AND INVESTORS FOR EVENTS RANGING FROM THE BIO INTERNATIONAL CONVENTION TO CONFERENCES FOR BUSINESS DEVELOPMENT EXECUTIVES. THE BIO INTERNATIONAL CONVENTION ATTRACTS OVER 15,000 OF THE MOST INFLUENTIAL BIOTECH AND PHARMA ATTENDEES FROM 65 COUNTRIES AND 49 U.S. STATES, INCLUDING 300 MEMBERS OF THE MEDIA, AND OFFERS THREE DAYS OF PROFESSIONAL AND BUSINESS DEVELOPMENT OPPORTUNITIES. THE NET INCOME FROM THE CONVENTION SUPPORTS OUR ADVOCACY, PUBLIC OUTREACH, AND OTHER MEMBER SERVICE ACTIVITIES.THE KEY ELEMENTS OF THE BIO INTERNATIONAL CONVENTION ARE EDUCATIONAL PROGRAMMING, EXHIBITION, THE BIO BUSINESS FORUM, AND NETWORKING EVENTS. THESE ELEMENTS PROVIDE AN OPPORTUNITY FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, ACADEMIC RESEARCH INSTITUTIONS, AND INVESTORS FROM AROUND THE WORLD TO LEARN ABOUT RECENT SCIENTIFIC AND POLICY DEVELOPMENTS, AND SCHEDULE ONE-ON-ONE MEETINGS TO DISCUSS POTENTIAL BUSINESS OPPORTUNITIES. IN 2014, THE BIO BUSINESS FORUM ALONE HELPED HOST A RECORD NUMBER OF OVER 27,000 PARTNERING MEETINGS AMONG MORE THAN 2,000 COMPANIES, ALONG WITH SOME 150 COMPANY PRESENTATIONS.BEYOND THE CONVENTION, BIO HOSTS OR CO-HOSTS A NUMBER OF NATIONAL AND INTERNATIONAL CONFERENCES THAT PROVIDE VENUES FOR MEMBER AND NON-MEMBER COMPANIES TO PRESENT NEW DATA, MEET AND PARTNER WITH FELLOW BIOTECH COMPANIES, AND ATTRACT FUNDING FROM INVESTORS AND OTHER ORGANIZATIONS. 0 0 1 1 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 155 0 190 1 1 1 1 IN 0 0 0 0 X 107 107 1 0 1 0 1 1 0 1 1 0 0 1 1 1 1 1 1 1 0 0 X JOANNE M DUNCAN 2029629200 1201 MARYLAND AVENUE SW NO 900 WASHINGTON DC 20024 ADAM MONROE VICE CHAIR FOR INDUSTRIAL & ENVIRONMENTAL 2.00 X X 0 0 0 ADELENE PERKINS MEMBER 2.00 X 0 0 0 ADRIAN ADAMS MEMBER 2.00 X 0 0 0 ALEX AZAR MEMBER 2.00 X 0 0 0 ALEXIS BORISY MEMBER 2.00 X 0 0 0 ALLEN WAXMAN MEMBER 2.00 X 0 0 0 ANDREW HINDMAN MEMBER 2.00 X 0 0 0 ANNA PROTOPAPAS MEMBER 2.00 X 0 0 0 ANNA RATH MEMBER 2.00 X 0 0 0 ANNALISA JENKINS MEMBER 2.00 X 0 0 0 ARLENE MORRIS MEMBER 2.00 X 0 0 0 ARTHUR SANDS MEMBER 2.00 X 0 0 0 ATUL THAKRAR MEMBER 2.00 X 0 0 0 BARBARA KOSACZ MEMBER 2.00 X 0 0 0 WILLIAM LIS MEMBER 2.00 X 0 0 0 BRADFORD ZAKES MEMBER 2.00 X 0 0 0 BRADLEY SHURDUT MEMBER 2.00 X 0 0 0 BRIAN ATWOOD MEMBER 2.00 X 0 0 0 CARLOS PAYA MEMBER 2.00 X 0 0 0 CENAN OZMERAL MEMBER 2.00 X 0 0 0 CHARLES EGGERT MEMBER 2.00 X 0 0 0 CHRISTI SHAW MEMBER 2.00 X 0 0 0 CHRISTIAN NOLET MEMBER 2.00 X 0 0 0 CHRISTOPHER STANDLEE MEMBER 2.00 X 0 0 0 DANIEL APEL MEMBER 2.00 X 0 0 0 DANIEL CUMMINGS MEMBER 2.00 X 0 0 0 DANIEL JUNIUS TREASURER 2.00 X X 0 0 0 DANIEL TASSE MEMBER 2.00 X 0 0 0 DAPHNE PREUSS MEMBER 2.00 X 0 0 0 DAVID PYOTT SECRETARY 2.00 X X 0 0 0 DAVID STACK MEMBER 2.00 X 0 0 0 DAVID MAIN MEMBER 2.00 X 0 0 0 DAVID MEEKER MEMBER 2.00 X 0 0 0 DAVID SCHENKEIN MEMBER 2.00 X 0 0 0 DEBORAH DUNSIRE MEMBER 2.00 X 0 0 0 DOUG BERVEN MEMBER 2.00 X 0 0 0 DOUGLAS DOERFLER MEMBER 2.00 X 0 0 0 EDDIE SULLIVAN MEMBER 2.00 X 0 0 0 EDWARD MATHERS MEMBER 2.00 X 0 0 0 EMER LEAHY MEMBER 2.00 X 0 0 0 FAHEEM HASNAIN MEMBER 2.00 X 0 0 0 FLEMMING ORNSKOV MEMBER 2.00 X 0 0 0 FRANCOIS NADER MEMBER 2.00 X 0 0 0 FRANK TERHORST MEMBER 2.00 X 0 0 0 FRANK VERWIEL MEMBER 2.00 X 0 0 0 GENO GERMANO MEMBER 2.00 X 0 0 0 GERALD STEINER MEMBER 2.00 X 0 0 0 GIL VAN BOKKELEN MEMBER 2.00 X 0 0 0 GLEN GIOVANNETTI MEMBER 2.00 X 0 0 0 GLENN GORMLEY MEMBER 2.00 X 0 0 0 GORDON MCCAULEY MEMBER 2.00 X 0 0 0 H THOMAS WATKINS MEMBER 2.00 X 0 0 0 HANS SCHIKAN MEMBER 2.00 X 0 0 0 HAROLD VAN WART MEMBER 2.00 X 0 0 0 HENRI TERMEER MEMBER 2.00 X 0 0 0 HERVE HOPPENOT MEMBER 2.00 X 0 0 0 HOWARD ROBIN MEMBER 2.00 X 0 0 0 IAN CLARK MEMBER 2.00 X 0 0 0 JAMES LEVINE MEMBER 2.00 X 0 0 0 JAY SIEGEL MEMBER 2.00 X 0 0 0 JEAN-FRANCOIS FORMELA MEMBER 2.00 X 0 0 0 JEAN-JACQUES BIENAIME MEMBER 2.00 X 0 0 0 JEFFREY HANKE MEMBER 2.00 X 0 0 0 JEFFREY OSTROVE MEMBER 2.00 X 0 0 0 JEFFREY HATFIELD MEMBER 2.00 X 0 0 0 JEFFREY WREN MEMBER 2.00 X 0 0 0 JERRY FLINT VICE CHAIR FOR FOOD & AGRICULTURE 2.00 X X 0 0 0 JOHN ORWIN MEMBER 2.00 X 0 0 0 JOHN CROWLEY MEMBER 2.00 X 0 0 0 JOHN MILLIGAN MEMBER 2.00 X 0 0 0 JOHN JOHNSON MEMBER 2.00 X 0 0 0 JOHN NICOLS MEMBER 2.00 X 0 0 0 JOHN MARAGANORE VICE CHAIR FOR EMERGING COMPANIES 2.00 X X 0 0 0 JOHN MENDLEIN MEMBER 2.00 X 0 0 0 JOHN SWART MEMBER 2.00 X 0 0 0 JONATHAN LEFF MEMBER 2.00 X 0 0 0 JONATHAN PEACOCK MEMBER 2.00 X 0 0 0 JONATHAN WOLFSON MEMBER 2.00 X 0 0 0 JOSEPH SHAULSON MEMBER 2.00 X 0 0 0 JULIE GERBERDING MEMBER 2.00 X 0 0 0 KENNETH MOCH MEMBER 2.00 X 0 0 0 KLAUS WILGENBUS MEMBER 2.00 X 0 0 0 KLEANTHIS XANTHOPOULOS MEMBER 2.00 X 0 0 0 KRISTINE PETERSON MEMBER 2.00 X 0 0 0 LAURA SCHUMACHER MEMBER 2.00 X 0 0 0 LUDWIG HANTSON MEMBER 2.00 X 0 0 0 MARC BEER MEMBER 2.00 X 0 0 0 MARC VERBRUGGEN MEMBER 2.00 X 0 0 0 MARK JONES MEMBER 2.00 X 0 0 0 MARK PRUZANSKI MEMBER 2.00 X 0 0 0 MARK SKALETSKY MEMBER 2.00 X 0 0 0 MARK TIMNEY MEMBER 2.00 X 0 0 0 MARK WONG MEMBER 2.00 X 0 0 0 MARKUS POMPEJUS MEMBER 2.00 X 0 0 0 MARTIN BABLER MEMBER 2.00 X 0 0 0 MATTHIAS MEDER MEMBER 2.00 X 0 0 0 MAXINE GOWEN MEMBER 2.00 X 0 0 0 MICHAEL NARACHI MEMBER 2.00 X 0 0 0 MICHAEL SEVERINO MEMBER 2.00 X 0 0 0 MICHELLE DIPP MEMBER 2.00 X 0 0 0 MONCEF SLAOUI MEMBER 2.00 X 0 0 0 NEAL GUTTERSON MEMBER 2.00 X 0 0 0 NEIL WARMA MEMBER 2.00 X 0 0 0 NICK LESCHLY MEMBER 2.00 X 0 0 0 PARIS PANAYIOTOPOULOS MEMBER 2.00 X 0 0 0 PATRICK GRUBER MEMBER 2.00 X 0 0 0 PAUL HUDSWON MEMBER 2.00 X 0 0 0 PAUL HASTINGS MEMBER 2.00 X 0 0 0 PAUL EISENBERG MEMBER 2.00 X 0 0 0 PERRY KARSEN MEMBER 2.00 X 0 0 0 PETER GREENLEAF MEMBER 2.00 X 0 0 0 PHILIP MILLER MEMBER 2.00 X 0 0 0 R JOHN GLASSPOOL MEMBER 2.00 X 0 0 0 RACHEL KING BOARD CHAIR 2.00 X X 0 0 0 RAYMOND SACCHETTI MEMBER 2.00 X 0 0 0 RICHARD ENO MEMBER 2.00 X 0 0 0 RICHARD POPS MEMBER 2.00 X 0 0 0 RICK WINNINGHAM MEMBER 2.00 X 0 0 0 ROBERT KISS MEMBER 2.00 X 0 0 0 ROBERT BEALL MEMBER 2.00 X 0 0 0 ROBIN READNOUR MEMBER 2.00 X 0 0 0 ROCH DOLIVEUS MEMBER 2.00 X 0 0 0 RON COHEN VICE CHAIR FOR HEALTHCARE 2.00 X X 0 0 0 RONALD STOTISH MEMBER 2.00 X 0 0 0 RUSSELL HERNDON MEMBER 2.00 X 0 0 0 RUSSELL MEDFORD MEMBER 2.00 X 0 0 0 SCOTT KOENIG MEMBER 2.00 X 0 0 0 STANLEY CROOKE MEMBER 2.00 X 0 0 0 STEPHAN TANDA MEMBER 2.00 X 0 0 0 STEPHEN SHERWIN MEMBER 2.00 X 0 0 0 STEVEN HOLTZMAN MEMBER 2.00 X 0 0 0 STEVEN MENTO MEMBER 2.00 X 0 0 0 STUART ARBUCKLE MEMBER 2.00 X 0 0 0 STUART PELTZ MEMBER 2.00 X 0 0 0 THOMAS MATHERS MEMBER 2.00 X 0 0 0 THOMAS TAYLOR MEMBER 2.00 X 0 0 0 TIMOTHY RODELL MEMBER 2.00 X 0 0 0 TIMOTHY WALBERT MEMBER 2.00 X 0 0 0 VINCENT MILANO MEMBER 2.00 X 0 0 0 WILLIAM FEEHERY MEMBER 2.00 X 0 0 0 WILLIAM FITZSIMMONS MEMBER 2.00 X 0 0 0 JAMES GREENWOOD CEO & PRESIDENT 40.00 X 3286030 0 41019 JOANNE DUNCAN CFO & SVP, FINANCE & ADMIN 40.00 X 424879 0 60357 A SCOTT WHITAKER COO 40.00 X 802829 0 146323 THOMAS DILENGE GENERAL COUNSEL & HEAD OF PUBLIC POLICY 40.00 X 555272 0 58924 FREDERICK BITTENBENDER EVP, PUBLIC AFFAIRS 40.00 X 512287 0 56261 AMY FINAN SVP, BUSINESS DEVELOPMENT 40.00 X 420340 0 46342 BRENT ERICKSON EVP, INDUSTRIAL & ENVIRONMENTAL 40.00 X 474825 0 48449 CARTIER ESHAM EVP, EMERGING COMPANIES 40.00 X 386937 0 42967 JOSEPH DAMOND SVP, INTERNATIONAL AFFAIRS 40.00 X 440824 0 59479 BRENT DELMONTE SVP, FEDERAL GOVERNMENT RELATIONS 40.00 X 515641 0 46827 SARA RADCLIFFE SVP, HEALTH 40.00 X 493752 0 53174 8313616 0 660122 78 0 1 0 FREEMAN EXPOSITIONS PO BOX 660613 DALLAS TX 75266 CONVENTION & CONFERENCES GENERAL CONTRAC 2010932 ARENT FOX 1717 K STREET NW WASHINGTON DC 20036 LEGAL CONSULTING SERVICES 1250778 PROJECTION INC PO BOX 890472 CHARLOTTE NC 28289 VIDEO SERVICES FOR CONVENTION & CONFEREN 830454 PERSONIFY INC 1919 GALLOWS ROAD SUITE 400 VIENNA VA 22182 AMS AND DATABASE MAINTENANCE SERVICES 795181 CENTERPLATE 111 W HARBOR DRIVE SAN DIEGO CA 92101 CATERING FOR INTERNATIONAL CONVENTION 781179 80 CONFERENCE/MEETING REVENUE 541800 33848757 33553282 295475 MEMBERSHIP DUES 900099 25095274 25095274 PUBLICATION ADVERTISING 541800 42000 42000 58986031 1497565 1497565 4758428 4758428 45050 45050 0 31642944 30105450 1537494 1537494 1537494 JOB BOARD REVENUE 900099 36705 36705 MISCELLANEOUS REVENUE 900099 1076 1076 37781 66817299 58648556 374180 7794563 588500 6410863 18407277 1827001 2779797 901709 269942 60954 1504000 373202 6024886 175859 1624006 824224 4101466 1237587 15999856 2206 1916141 804146 119758 TAXES PAID 75126 EDUCATION 30842 BAD DEBT EXPENSE 26760 OUTREACH 3166 43690 66132964 1370438 2183816 2836623 2694981 1511943 1857354 10766570 8467276 2506902 2299294 58266627 58908990 146440 140578 66638973 68085013 11686388 11562927 8913117 9132296 5554377 5320759 26153882 26015982 X 40485091 42069031 40485091 42069031 66638973 68085013 X 684335 859118 40487 X 0 1 X 1 0 5000 0 5000 0 5000 1 NEWSOM FOR CALIFORNIA LIETUENANT GOVERNOR 9869 EASTON DR BEVERLY HILLS CA 90210 273872296 5000 0 0 0 1 25095274 7865953 33386 7899339 8281440 -382101 PART I-A, LINE 1: BIO'S ONLY 2014 DIRECT POLITICAL CAMPAIGN ACTIVITY WAS A $5,000 CONTRIBUTION MADE TO NEWSOM FOR CALIFORNIA LIEUTENANT GOVERNOR. BIO DID NOT HAVE ANY INDIRECT POLITICAL CAMPAIGN ACTIVITY IN 2014. 5988846 4262345 1726501 1967376 1817242 150134 2810348 2387689 422659 2299294 CAPITAL LEASE OBLIGATION 150349 DEFERRED RENT 5170410 5320759 69879469 859118 2576254 3435372 66444097 373202 373202 66817299 68295529 2535767 2535767 65759762 373202 373202 66132964 PART XI, LINE 2D - OTHER ADJUSTMENTS: CBI LOBBYING FUND 856,950. FOOD & AG INITIATIVES REVENUE 32,064. FOOD & AG LEGAL FUND 1,218,240. BIOSIMILARS REVENUE 469,000. PART XII, LINE 2D - OTHER ADJUSTMENTS: CBI LOBBYING FUND 828,095. FOOD & AG INITIATIVES REVENUE 32,064. FOOD & AG LEGAL FUND 1,218,240. BIOSIMILAR EXPENSES 457,368. EUROPE (INCLUDING ICELAND & GREENLAND) 0 2 PROGRAM SERVICES CONFERENCES AND ADVOCACY 286103 SOUTH ASIA 0 1 PROGRAM SERVICES ADVOCACY 18645 EAST ASIA AND THE PACIFIC 0 2 PROGRAM SERVICES CONFERENCES AND ADVOCACY 499156 NORTH AMERICA 0 0 PROGRAM SERVICES CONFERENCES AND ADVOCACY 1469 SOUTH AMERICA 0 3 PROGRAM SERVICES CONFERENCES AND ADVOCACY 229294 0 8 0 0 0 8 1034667 0 1034667 0 0 0 0 0 0 1 INFORMATION TECHNOLOGY AND INNOVATION FOUNDATION 1101 K STREET SUITE 610 WASHINGTON DC 20005 204403497 501(C)(3) 25000 GENERAL SUPPORT US CHAMBER OF COMMERCE 1615 H STREET NW WASHINGTON DC 20062 530045720 501(C)(6) 40000 GENERAL SUPPORT AMERICAN ENTERPRISE INSTITUTE FOR PBULIC POLICY RESEARCH 1150 17TH STREET NW WASHINGTON DC 20036 530218495 501(C)(3) 25000 GENERAL SUPPORT TRUSTEES OF TUFTS COLLEGE 75 KNEELAND STREET SUITE 1100 BOSTON MA 02111 042103634 501(C)(3) 11000 SPONSORSHIP GEORGE MASON UNIVERSITY FOUNDATION INC 4400 UNIVERSITY DRIVE FAIRFAX VA 22030 541603842 501(C)(3) 15000 GENERAL SUPPORT WASHINGTON LEGAL FOUNDATION 2009 MASSACHUSETTS AVENUE NW WASHINGTON DC 20036 521071570 501(C)(3) 10000 GENERAL SUPPORT NATIONAL COALITION FOR CANCER SURVIVORSHIP 1010 WAYNE AVENUE SUITE 315 SILVER SPRING MD 20910 850357897 501(C)(3) 15000 GENERAL SUPPORT BIOFLORIDA INC 525 OKEECHOBEE BLVD STE 1500 WEST PALM BEACH FL 33401 593436638 501(C)(6) 5500 SPONSORSHIP BIO NEBRASKA LIFE SCIENCES ASSOCIATION 9290 W DOGE ROAD SUITE 104 OMAHA NE 68114 202214508 501(C)(6) 7500 SPONSORSHIP PENNSYLVANIA BIOTECHNOLOGY ASSOCIATION 650 E SWEDESFORD ROAD SUITE 190 WAYNE PA 19087 251621500 501(C)(6) 20000 SPONSORSHIP DELAWARE BIOSCIENCE ASSOCIATION 1 INNOVATION WAY SUITE 300 NEWARK DE 19711 204147195 501(C)(6) 6000 SPONSORSHIP SOUTH CAROLINA BIOTECH ASSOCIATION 411 UNIVERSITY RIDGE SUITE A GREENVILLE SC 29601 200613951 501(C)(3) 10000 SPONSORSHIP GEORGIA BIOSCIENCES ORGANIZATION 1199 EUCLID AVENUE NE ATLANTA GA 30307 273855537 501(C)(6) 10000 GENERAL SUPPORT MICHIGAN BIOSCIENCES INDUSTRY ASSOCIATION 3520 GREEN ROAD SUITE 150 ANN ARBOR MI 48105 383142021 501(C)(6) 7500 GENERAL SUPPORT GLOBAL HEALTHY LIVING FOUNDATION INC 515 NORTH MIDLAND AVE UPPER NYACK NY 10960 204039120 501(C)(3) 15000 SPONSORSHIP LEUKEMIA & LYMPHOMA SOCIETY 3601 EISENHOWER AVNEUE SUITE 400 ALEXANDRIA VA 22304 135644916 501(C)(3) 25000 SPONSORSHIP AMERICAN CANCER SOCIETY 1710 WEBSTER STREET OAKLAND CA 94612 131788491 501(C)(3) 10000 SPONSORSHIP SOCIETY FOR WOMENS HEALTH RESEARCH 1025 CONNECTICUT AVE NW SUITE 601 WASHINGTON DC 20036 521694732 501(C)(3) 15000 SPONSORSHIP NATIONAL MULTIPLE SCIEROSIS SOCIETY 1800 M STREET NW SUITE 750 SOUTH WASHINGTON DC 20036 530237585 501(C)(3) 6500 SPONSORSHIP NATIONAL ORGANIZATION FOR RARE DISORDERS INC 55 KENOSIA AVENUE DANBURY CT 06810 133223946 501(C)(3) 10000 SPONSORSHIP THE JAMES BEARD FOUNDATION 167 WEST 12TH STREET NEW YORK NY 10011 132752108 501(C)(3) 100000 GENERAL SUPPORT ALLIANCE FOR PATIENT ACCESS 6227 EAGLE RIDGE ROAD BETTENDORF IA 52722 205130312 501(C)(4) 30000 PROGRAM ACTIVITIES ALLIANCE FOR AGING RESEARCH 1700 K STREET NW SUITE 740 WASHINGTON DC 20006 541379174 501(C)(3) 10000 SPONSORSHIP THE MILKEN INSTITUTE 1250 FOURTH STREET 2ND FLOOR SAN MONICA CA 90401 954240775 501(C)(3) 20000 SPONSORSHIP THE CONGRESSIONAL HUNGER CENTER 400 N CAPITOL ST NW SG100 WASHINGTON DC 20001 521842738 501(C)(3) 10000 SPONSORSHIP COMPETITIVE ENTERPRISE INSTITUTE 1899 L ST NW 12TH FLOOR WASHINGTON DC 20036 521351785 501(C)(3) 10000 SPONSORSHIP 18 8 PART I, LINE 2: BIO RELIES ON THE REQUIRED QUALIFICATIONS OF THE GRANT RECIPIENTS TO PROVIDE ASSURANCE OF PROPER USAGE. IN SOME CASES, BIO PERSONNEL ATTEND EVENTS AND RECEIVE ACKNOWLEDGEMENTS RELATED TO THE FUNDS GRANTED. X X X 1 1 X X X X X X 0 1 0 JAMES GREENWOOD CEO & PRESIDENT 1112623 0 672000 0 1501407 0 30251 0 10768 0 3327049 0 1351850 0 JOANNE DUNCAN CFO & SVP, FINANCE & ADMIN 320536 0 104343 0 0 0 30251 0 30106 0 485236 0 0 0 A SCOTT WHITAKER COO 604992 0 197837 0 0 0 118571 0 27752 0 949152 0 0 0 THOMAS DILENGE GENERAL COUNSEL & HEAD OF PUBLIC POL 418439 0 136833 0 0 0 30251 0 28673 0 614196 0 0 0 FREDERICK BITTENBENDER EVP, PUBLIC AFFAIRS 385455 0 126832 0 0 0 30251 0 26010 0 568548 0 0 0 AMY FINAN SVP, BUSINESS DEVELOPMENT 314626 0 105714 0 0 0 30251 0 16091 0 466682 0 0 0 BRENT ERICKSON EVP, INDUSTRIAL & ENVIRONMENTAL 358006 0 116819 0 0 0 30251 0 18198 0 523274 0 0 0 CARTIER ESHAM EVP, EMERGING COMPANIES 296217 0 90720 0 0 0 30251 0 12716 0 429904 0 0 0 JOSEPH DAMOND SVP, INTERNATIONAL AFFAIRS 332466 0 108358 0 0 0 30251 0 29228 0 500303 0 0 0 BRENT DELMONTE SVP, FEDERAL GOVERNMENT RELATIONS 388752 0 126889 0 0 0 30251 0 16576 0 562468 0 0 0 SARA RADCLIFFE SVP, HEALTH 372109 0 121643 0 0 0 30251 0 22923 0 546926 0 0 0 PART I, LINE 1A JAMES GREENWOOD NOT INCLUDED IN TAXABLE COMPENSATION TO THE INDIVIDUAL: - FIRST CLASS OR CHARTER TRAVEL - $33,836 - HEALTH OR SOCIAL CLUB DUES - $5,000 INCLUDED IN TAXABLE COMPENSATION TO THE INDIVIDUAL: - TRAVEL FOR COMPANIONS - $16,794 PART I, LINE 4B JAMES GREENWOOD - 457(F) $1,463,424 SCOTT WHITAKER - 457(F) $88,320 FORM 990, PART IV, LINE 11F: AS PART OF THE AUDIT CONDUCTED FOR THE ORGANIZATION A FIN 48 (ASC 740) ANALYSIS IS COMPLETED. IT WAS DETERMINED THAT NO UNCERTAIN TAX POSITIONS EXISTED AND AS SUCH THERE IS NO FOOTNOTE IN THE FINANCIAL STATEMENTS THAT DISCUSSES FIN 48 (ASC 714). FORM 990, PART VI, SECTION A, LINE 1 THE BOARD OF DIRECTORS SHALL DESIGNATE, BY RESOLUTION AND WITH A QUORUM PRESENT, NOT MORE THAN NINETEEN (19) DIRECTORS OF THE BOARD TO ACT AS AN EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL CONSIST OF THE SEVEN (7) ELECTED OFFICERS OF THE ORGANIZATION (AS DEFINED IN ARTICLE VIII); THE IMMEDIATE PAST CHAIR OF THE ORGANIZATION; THE VICE CHAIRS OF EACH SECTION'S GOVERNING BOARD; AND THE BALANCE BEING AT-LARGE DIRECTORS FROM THE FULL BOARD. IF THE IMMEDIATE PAST CHAIR IS NO LONGER ELIGIBLE TO SERVE ON THE FULL BOARD, AN ADDITIONAL AT-LARGE DIRECTOR FROM THE FULL BOARD SHALL BE SELECTED FOR THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL HAVE, AND BE AUTHORIZED TO EXERCISE, ALL POWERS OF THE FULL BOARD, EXCEPT: (A) THE POWER TO ELECT OR REMOVE ELECTED OFFICERS OR DIRECTORS, TO CHANGE THE SIZE OF THE BOARD, TO CHANGE ELIGIBILITY, QUALIFICATIONS OR RIGHTS OF MEMBERSHIP, TO APPROVE THE FINANCIAL BUDGET FOR THE ORGANIZATION, OR TO MAKE DETERMINATIONS AS TO DIRECTOR AND OFFICER COMPENSATION, WHERE APPLICABLE; AND (B) THE POWER TO AMEND THE ARTICLES OF INCORPORATION OR THE BYLAWS OF THE ORGANIZATION. THE EXECUTIVE COMMITTEE SHALL REPORT TO THE BOARD OF DIRECTORS AT THE NEXT MEETING ON ITS ACTIONS SINCE THE LAST MEETING OF THE FULL BOARD AND SUBMIT SUCH ACTIONS FOR RATIFICATION BY THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 2 BASED ON RESPONSES TO A SURVEY DISTRIBUTED TO EACH MEMBER OF BIO'S BOARD OF DIRECTORS, TWO DIRECTORS - KRISTINE PETERSON AND DANIEL JUNIUS -- HAD A BUSINESS RELATIONSHIP IN 2014 AS DEFINED BY THE FORM 990 INSTRUCTIONS FORM 990, PART VI, SECTION A, LINE 4 THE BYLAWS WERE AMENDED ON JUNE 23, 2014, TO ENACT THE FOLLOWING CHANGES: (1) TO ALTER THE SIZE AND COMPOSITION OF THE HEALTH SECTION GOVERNING BOARD SO AS TO PERMIT GREATER PARTICIPATION BY LARGE FIRMS MEMBERS, WHILE ENSURING THAT EMERGING AND ESTABLISHED COMPANIES MAINTAIN A MAJORITY OF AVAILABLE SEATS ON THE GOVERNING BOARD AND ON THE RELEVANT NOMINATING COMMITTEE; AND (2) TO ELIMINATE THE RESTRICTIONS REGARDING THE PERCENTAGE OF "DESIGNATED OFFICERS" FROM LARGE FIRMS ON THE SECTION GOVERNING BOARDS, WHILE PROVIDING ADDITIONAL GUIDANCE TO THE RELEVANT NOMINATING COMMITTEES ON THE FACTORS THAT ARE RELEVANT TO ASSESSING THE CREDENTIALS OF PROPOSED DESIGNATED OFFICERS. FORM 990, PART VI, SECTION A, LINE 6 THE MEMBERS OF THE ORGANIZATION SHALL BE DIVIDED INTO FOUR CLASSES; CORE MEMBERS, ASSOCIATE MEMBERS, AFFILIATE MEMBERS, AND CENTER MEMBERS, DEFINED AS FOLLOWS: (A) CORE MEMBERS. ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PERCENTAGE OF WHOSE BUSINESS ACTIVITIES INVOLVE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR RELATED NEW TECHNOLOGIES, IS ELIGIBLE FOR MEMBERSHIP. CORE MEMBERS ARE THOSE ENTITIES THAT UTILIZE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR OTHER RELATED NEW TECHNOLOGIES IN RESEARCH, DEVELOPMENT, TESTING, MANUFACTURING, OR SALES OF PRODUCT OR INFORMATION, AS WELL AS OTHER FIRMS THE BOARD SO CHARACTERIZES AND PLACES IN THIS CATEGORY. CORE MEMBERS SHALL BE GROUPED IN THE FOLLOWING SUBCATEGORIES: (I) EMERGING COMPANIES, WHICH ARE FIRMS THAT EMPLOY LESS THAN 350 PERSONS AND THAT DO NOT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; (II) ESTABLISHED FIRMS, WHICH ARE THOSE FIRMS THAT EMPLOY 350 OR MORE PERSONS OR THAT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; AND (III) LARGE FIRMS, WHICH ARE ESTABLISHED FIRMS THAT HAVE ANNUAL WORLDWIDE SALES OF BIOTECHNOLOGY PRODUCTS IN EXCESS OF $1.5 BILLION; AND (IV) NON-DOMESTIC COMPANIES, WHICH ARE CORE MEMBERS WITHOUT SIGNIFICANT OPERATIONS IN THE UNITED STATES OR SIGNIFICANT COLLABORATIONS WITH A U.S. ENTITY. (B) ASSOCIATE MEMBERS. ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PORTION OF WHOSE ACTIVITIES INVOLVE PROVIDING SERVICES OR PRODUCTS OF BENEFIT TO COMPANIES WHOSE PRINCIPAL BUSINESS IS BIOTECHNOLOGY, IS ELIGIBLE FOR ASSOCIATE MEMBERSHIP. ASSOCIATE MEMBERS ARE THOSE COMMERCIAL ENTITIES WHICH DO NOT NECESSARILY UTILIZE BIOTECHNOLOGY; E.G. TECHNICAL SUPPORT, EQUIPMENT, CONSTRUCTION, ACCOUNTING, AND LAW FIRMS THAT SERVICE THE BIOTECHNOLOGY INDUSTRY, AS WELL AS OTHER FIRMS THAT THE BOARD CHARACTERIZES AND PLACES IN THIS CATEGORY. (C) AFFILIATE MEMBERS. ANY GOVERNMENTAL OR NONPROFIT ENTITY OR COUNTRY, STATE OR REGIONAL INDUSTRY, TRADE OR PROFESSIONAL ASSOCIATION WITH AN INTEREST IN, OR A MANDATE TO PROMOTE THE DEVELOPMENT OF, BIOTECHNOLOGY IS ELIGIBLE FOR AFFILIATE MEMBERSHIP. THERE SHALL BE NO SIZE TESTS APPLIED TO AFFILIATE MEMBER APPLICANTS. (D) CENTER MEMBERS. ANY INSTITUTION, NOT GENERALLY ELIGIBLE FOR CORE MEMBERSHIP THAT IS SPONSORED BY A STATE, REGION, OR ACADEMIC INSTITUTION AND WORKS IN SUPPORT OF COMMERCIAL BIOTECHNOLOGY MAY BE ELIGIBLE FOR CONSIDERATION AS A CENTER MEMBER. FORM 990, PART VI, SECTION A, LINE 7A AT ALL MEMBERSHIP MEETINGS OF THE ORGANIZATION, EACH CURRENT MEMBER SHALL HAVE ONE (1) VOTE AND MAY TAKE PART IN THE VOTING IN PERSON OR BY PROXY. FOR EACH SECTION IN WHICH THE MEMBER PARTICIPATES, EACH MEMBER SHALL HAVE THE RIGHT TO VOTE ON THE ELECTION OF DIRECTORS FOR THE SECTION GOVERNING BOARD, BUT SHALL HAVE NO OTHER VOTING RIGHTS EXCEPT ON MATTERS BROUGHT TO THE MEMBERSHIP BY ANY SUCH GOVERNING BOARD OR THE ORGANIZATION'S BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11 THE FORM 990 AND RELATED SCHEDULES ARE PREPARED BY THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS UNDER THE GUIDANCE OF THE CFO. THE CFO AND THE CONTROLLER THOROUGHLY REVIEW ALL CALCULATIONS AND SCHEDULES TO CONFIRM THEY REFLECT THE ACTUAL FINANCIAL RESULTS OF THE ORGANIZATION. THE COMPLETE FORM 990 IS THEN REVIEWED INTERNALLY BY THE CEO, COO, CFO, AND CONTROLLER IN CONSULTATION WITH LEGAL COUNSEL AND, AS APPROPRIATE, FURTHER CONSULTATION WITH THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS. FINALLY, ONCE ALL INTERNAL REVIEWS ARE COMPLETED, THE FORM 990 IS PROVIDED TO THE CHAIRMAN OF THE BOARD AND ALL MEMBERS OF THE BIO EXECUTIVE COMMITTEE FOR THEIR REVIEW, QUESTIONS AND/OR COMMENTS, PRIOR TO FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C BIO TAKES SEVERAL STEPS TO ADDRESS COMPLIANCE BY EMPLOYEES AND DIRECTORS WITH ITS CONFLICTS OF INTEREST POLICY. BIO TRAINS ALL NEW EMPLOYEES AND DIRECTORS ON VARIOUS ASPECTS OF BIO'S COMPLIANCE PROGRAM, INCLUDING CONFLICTS OF INTEREST, AND BIO'S WRITTEN CONFLICTS OF INTEREST POLICY REQUIRES ALL EMPLOYEES TO DISCLOSE ANY OUTSIDE PERSONAL BUSINESS INTERESTS TO THEIR SUPERVISOR. BIO'S GENERAL COUNSEL REGULARLY ADVISES BIO'S EXECUTIVES AND SUPERVISORS ON SUCH MATTERS. BIO ALSO CONTRACTS WITH AN INDEPENDENT ORGANIZATION TO PROVIDE EMPLOYEES AND OTHERS WITH THE ABILITY TO FILE ANONYMOUS REPORTS CONCERNING THE VIOLATION OF ANY LAWS OR BIO POLICIES, INCLUDING ALLEGATIONS OF POTENTIAL CONFLICTS OF INTEREST, AND BIO HAS A PROCESS IN PLACE TO FOLLOW UP ON ANY SUCH COMPLAINTS IN A TIMELY AND THOROUGH MANNER. FURTHER, BIO UNDERTAKES A QUESTIONNAIRE SENT ANNUALLY TO EACH MEMBER OF ITS BOARD OF DIRECTORS SEEKING DISCLOSURE OF ANY POTENTIAL CONFLICTS OF INTERESTS THEY MAY HAVE, OR THEIR FAMILY MEMBERS MAY HAVE, ASSOCIATED WITH BUSINESSES OR ORGANIZATIONS THAT DO BUSINESS WITH BIO. POTENTIAL CONFLICTS ARE MONITORED AND REVIEWED AT THE MANAGEMENT AND SENIOR MANAGEMENT LEVEL OF THE ORGANIZATION, AND DEPENDING ON THE CONFLICT, DETERMINATIONS MAY BE MADE AT THE BOARD OR SENIOR MANAGEMENT LEVEL. A CONFLICT AT THE BOARD LEVEL WILL NORMALLY RESULT IN RECUSAL OF THE INDIVIDUAL FROM PARTICIPATION OR ACTIVITIES WITH RESPECT TO THE RELEVANT SUBJECT MATTER. AT THE STAFF LEVEL, THE APPLICABLE BIO SUPERVISOR IS INFORMED OF THE POTENTIAL CONFLICT AND IS REQUIRED TO TAKE ALL APPROPRIATE STEPS TO ENSURE THAT THE INDIVIDUAL DOES NOT PARTICIPATE IN, OR RECEIVE CONFIDENTIAL INFORMATION RELATING TO, ANY BIO ACTIVITY RELATED TO THE SUBJECT MATTER OF THE CONFLICT, UP TO AND INCLUDING, WHERE APPROPRIATE, TERMINATION OF SUCH EMPLOYEE. FORM 990, PART VI, SECTION B, LINE 15A THE PERFORMANCE AND COMPENSATION OF THE PRESIDENT AND CEO OF BIO FOR 2014 WAS REVIEWED AND DETERMINED IN A PROCESS THAT WAS LED BY THE CHAIRMAN OF THE BOARD AND INVOLVED THE FULL EXECUTIVE COMMITTEE OF THE BOARD. THE BIO EXECUTIVE COMMITTEE, WHICH IS COMPRISED OF INDEPENDENT BIO BOARD MEMBERS, LEADS AND UNDERTAKES THIS ANNUAL PROCESS. IF NEEDED IN CARRYING OUT THIS PROCESS, THE MEMBERS OF THE EXECUTIVE COMMITTEE CAN BE ASSISTED AND COUNSELED BY BOTH INDEPENDENT OUTSIDE LEGAL COUNSEL WHO IS AN EXPERT IN THIS AREA OF THE LAW, AND AN INDEPENDENT OUTSIDE CONSULTANT THAT PROVIDES BENCHMARKING SERVICES AND INFORMATION ON EXECUTIVE COMPENSATION ISSUES. THE UNDERLYING EXECUTIVE EMPLOYMENT AGREEMENT WAS REVISED AND EXTENDED IN 2014, IN CONSULTATION WITH EXTERNAL INDEPENDENT LEGAL AND COMPENSATION CONSULTANTS AND WITH THE FULL BOARD OF DIRECTORS, AND WITH FINAL APPROVAL BY THE EXECUTIVE COMMITTEE OF THE BOARD. BASED ON THE EXECUTIVE COMMITTEE'S EVALUATION OF THE PRESIDENT AND CEO'S PERFORMANCE FOR 2014, INCLUDING REVIEW OF HIS OBJECTIVES AND SELF-ASSESSMENT, THE COMMITTEE DETERMINED THE APPROPRIATE AMOUNT FOR THE DISCRETIONARY COMPONENT OF HIS COMPENSATION FOR THAT YEAR, IN ACCORDANCE WITH PROVISIONS OF THE EXECUTIVE AGREEMENT. THE PROCESS OF THIS REVIEW WAS DOCUMENTED IN THE JANUARY 2014 EXECUTIVE COMMITTEE MEETING MINUTES. IN ADDITION, THE INFORMATION RELATED TO COMPENSATION CHANGES ARE DISCUSSED IN THE EXECUTIVE AGREEMENT OR COMMUNICATED TO THE CFO VIA EMAIL BY THE CHAIRMAN OF THE BOARD. FORM 990, PART VI, SECTION B, LINE 15B: DECISIONS REGARDING THE COMPENSATION FOR OFFICERS AND KEY EMPLOYEES OF THE ORGANIZATION ARE NEGOTIATED INDIVIDUALLY AND ARE PERFORMANCE-BASED, IN ACCORDANCE WITH AN ANNUAL WRITTEN EVALUATION PROCESS THAT HAS BEEN ESTABLISHED FOR ALL EMPLOYEES OF THE ORGANIZATION. THE CHIEF OPERATING OFFICER LEADS AND UNDERTAKES THIS PROCESS, IN COORDINATION WITH THE PRESIDENT & CEO. AN INDEPENDENT CONSULTANT PROVIDES COMPARATIVE BENCHMARKING SERVICES FOR SENIOR MANAGEMENT POSITIONS, AND OTHER INFORMATION ON COMPENSATION ISSUES, TRENDS, POLICIES, AND BEST PRACTICES FOR USE BY THE ORGANIZATION. THE ORGANIZATION ALSO HAS AN ESTABLISHED COMPENSATION POLICY FOR ALL OF ITS EMPLOYEES, WHICH SETS FORTH THE GENERAL PARAMETERS GOVERNING BIO'S COMPENSATION PRACTICES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. FORM 990, PART XI, LINE 9: CBI LOBBYING FUND REVENUE 856,950. CBI LOBBYING FUND EXPENSE -828,095. FOOD & AG INITIATIVES REVENUE 32,064. FOOD & AG INITIATIVES EXPENSES -32,064. FOOD & AG LEGAL FUND REVENUE 1,218,240. FOOD & AG LEGAL FUND EXPENSES -1,218,240. BIOSIMILARS REVENUE 469,000. BIOSIMILARS EXPENSE -457,368.